Sentences with phrase «cancer immunotherapy strategies»

These results, published in Nature Communications, have the potential to improve current cancer immunotherapy strategies, especially in relation to the prevention of metastasis (dissemination of the tumor to organs distant from the site of origin).

CRI provides a pilot grant to Jean - Pierre Mach for preclinical studies to test a new cancer immunotherapy strategy using anti-tumor antibody fragments conjugated to antigenic MHC / peptide complexes.

Not exact matches

«Discovery opens door to new strategy for cancer immunotherapy.»

In addition to formulating diagnostic strategies for cancer immunotherapy agents, her team is focused on developing a deep understanding of tumor immune biology as well as mechanisms associated with immune response and immune escape in cancer patients, with the intent of generating rational strategies for the creation of combination therapies.

So Swanton is focusing on immunotherapies — strategies that help the immune system to recognize and destroy cancer cells.

The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell — one circulating in the blood and the other resident in tissues — that can be reactivated with current immunotherapy strategies.

«Our results in experimental models of cancer suggest a new therapeutic strategy based on inhibiting the microRNA machinery — or the Let - 7 microRNAs — specifically in the TAMs, which may unleash the power of mainstream immunotherapies, such as immune checkpoint inhibitors.»

Through such an understanding it will be possible to block the tumor's immune evasion strategy which in turn will result in the cancer patient responding more effectively to an anti-cancer immunotherapy.

She translates the most promising immunotherapy strategies for breast cancer to the clinic, and is now extending these strategies to ovarian cancer.

Targeting negative regulators downstream of the TCR represents a novel strategy to improve cancer immunotherapy.

«The IASLC, being a global, multidisciplinary organization, is uniquely positioned to coordinate a harmonized strategy that can bring people together to show how the culture of lung cancer should reflect hope, as advances in lung cancer screening and early detection, personalized therapies, and immunotherapies are making a real impact in patients» lives.»

We are developing cutting - edge discovery platforms and product strategies for effective cancer immunotherapies that we believe take into consideration the limitations of other approaches, as well as leveraging different mechanisms of action to address the risk of reliance on a single approach.

This has led to a successful strategy for cancer immunotherapy: block the pathways that tumors use to turn off the immune response.

The intent of the effort is to build off the identified immunologic factors that may be modulated to improve immunotherapy for CRC patients, with the goal that the biomarkers and treatment strategies identified in the manuscript will become part of the routine management of colorectal cancer (CRC).

«Insights derived from these data will be critical to improving the effectiveness of current cancer immunotherapy treatments and developing new immune - based treatment strategies,» said Justin Guinney, Ph.D., principal investigator, director of computational oncology and bioinformatics at Sage Bionetworks.

Cancer immunotherapy is showing huge promise as a cancer treatment strCancer immunotherapy is showing huge promise as a cancer treatment strcancer treatment strategy.

A novel approach to cancer immunotherapy — strategies designed to induce the immune system to attack cancer cells — may provide a new and cost - effective weapon against some of the most deadly tumors, including ovarian cancer and mesothelioma.

In an effort to accelerate the development, refinement, and approval of more cancer immunotherapies, the Cancer Research Institute has a developed a comprehensive strategy that draws upon several complementary resources and procancer immunotherapies, the Cancer Research Institute has a developed a comprehensive strategy that draws upon several complementary resources and proCancer Research Institute has a developed a comprehensive strategy that draws upon several complementary resources and programs.

In doing so, he is devising inventive strategies to circumvent the hurdles that prevent immunotherapy from being cost - effective, widely available and effective against many types of cancer.

Although cancer immunotherapy is changing the paradigm of how cancer is treated, there is an urgent need to develop predictive biomarkers to identify patients who are most likely to benefit from various immunotherapeutic strategies.